ForrestSwanJr.MD

Oncology • Abingdon, VA

Physician

Join to view full profile

Are you Dr. Swan?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 48 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
104 Abingdon Pl
Abingdon, VA 24211
Phone+1 276-676-1860

Fax+1 276-628-2917
Is this information wrong?

Summary

Dr. Forrest Swan Jr., MD is an oncologist in Abingdon, Virginia. He is currently licensed to practice medicine in Virginia, West Virginia, and Colorado. He is affiliated with LeConte Medical Center and Charleston Area Medical Center.

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
Loyola University Medical CenterResidency, Internal Medicine, 1978 - 1981
University of Illinois College of MedicineClass of 1978

Certifications & Licensure

FL State Medical License 1982 - 2026
HI State Medical License 2018 - 2026
WV State Medical License 2021 - 2025
VA State Medical License 1996 - 2024
TN State Medical License 1996 - 2024
WI State Medical License 1980 - 2023
CO State Medical License 2019 - 2023
TX State Medical License 1985 - 1996
IL State Medical License 1980 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Join now to see all

Clinical Trials

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Start of enrollment: 2003 Jan 01
Unknown status
Phase 4

Publications & Presentations

PubMed

83 citations
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.
Juan Luis Polo Rodríguez, Maria A Rodriguez, Luis Fayad, Patricia J. McLaughlin, F. Swan, Andreas H. Sarris, Jorge E. Romaguera, Borje S. Andersson, Fernando Cabanilla...> ;Blood. 1999 Jun 1
222 citations
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
Peter McLaughlin, Fredrick B. Hagemeister, Jorge E. Romaguera, Andreas H. Sarris, Odeal Pate, Anas Younes, F. Swan, Michael J. Keating, Fernando Cabanillas> ;Journal of Clinical Oncology. 1996 Apr 1
19 citations
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule.
Anas Younes, Jean Pierre Ayoub, Fredrick B. Hagemeister, Peter McLaughlin, Andreas H. Sarris, Maria A Rodriguez, F. Swan, Jorge E. Romaguera, John E. Martin, Fernando ...> ;Journal of Clinical Oncology. 1996 Feb 1
33 citations
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Andreas H. Sarris, Anas Younes, Peter McLaughlin, Dennis F. Moore, Frederick B. Hagemeister, F. Swan, Maria A Rodriguez, Jorge E. Romaguera, L. B. North, Paul F. Mansf...> ;Journal of Clinical Oncology. 1996 Jan 1
90 citations
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
Maria Alma Rodriguez, F. C. Cabanillas, W. S. Velasquez, Fredrick B. Hagemeister, Patricia J. McLaughlin, F. Swan, Jorge E. Romaguera> ;Journal of Clinical Oncology. 1995 Jul 1
3 citations
Relationship between DNA ploidy level, nuclear size, and survival in large cell lymphoma.
Isabelle Salmon, Forrest Swan, Jean-Louis Dargent, Jean Lambert Pasteels, Robert Kiss, Ruth L. Katz> ;American Journal of Clinical Pathology. 1995 May 1
33 citations
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma.
Ahmed I. Younes, Andreas H. Sarris, A Melnyk, J. E. Romaguera, P. McLaughlin, F. Swan, Maria A Rodriguez, Fredrick B. Hagemeister, Dennis F. Moore, L. B. North> ;Journal of Clinical Oncology. 1995 Mar 1
4 citations
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: A phase II study
Dennis F. Moore, F. Swan, J. Yau, Maria Alma Rodriguez, Patricia J. McLaughlin, Andreas H. Sarris, Jorge E. Romaguera, Anas Younes, Fredrick B. Hagemeister, Fernando C...> ;Clinical Oncology. 1995 Jan 1
20 citations
Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase
Samer Suki, F. Swan, Susan L. Tucker, Herbert A. Fritsche, John R. Redman, Maria Alma Rodriguez, Peter McLaughlin, Jorge E. Romaguera, Fredrick B. Hagemeister, William...> ;Leukemia & Lymphoma. 1995 Jan 1
47 citations
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation
Lillian M. Fuller, Matthew J. Krasin, W. S. Velasquez, Pamela K. Allen, Peter McLaughlin, M. Alma Rodriguez, Fredrick B. Hagemeister, F. Swan, Fernando Cabanillas, J. ...> ;International Journal of Radiation Oncology, Biology, Physics. 1995 Jan 1
2 citations
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cispl...
Jorge E. Romaguera, Maria A Rodriguez, Frederick B. Hagemeister, Peter McLaughlin, F. Swan, Dennis F. Moore, Andreas H. Sarris, Anas Younes, Debbie Hill, Fernando Caba...> ;Investigational New Drugs. 1994 Sep 1
366 citations
ESHAP--an Effective Chemotherapy Regimen in Refractory and Relapsing Lymphoma: A 4-year Follow-Up Study
W. S. Velasquez, P. McLaughlin, Susan L. Tucker, Fredrick B. Hagemeister, F. Swan, Maria A Rodriguez, Jorge E. Romaguera, E. Rubenstein, Fernando Cabanillas> ;Journal of Clinical Oncology. 1994 Jun 1
13 citations
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin-vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamet...
William S. Velasquez, Peter McLaughlin, Lillian M. Fuller, Pamela K. Allen, Susan L. Tucker, Forrest Swan, Maria A. Rodriguez, Fredrick B. Hagemeister, Fernando Cabani...> ;Cancer. 1994 May 1
87 citations
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
Peter McLaughlin, Fredrick B. Hagemeister, F. Swan, Fernando Cabanillas, Odeal Pate, Jorge E. Romaguera, Maria A Rodriguez, John R. Redman, Michael J. Keating> ;Journal of Clinical Oncology. 1994 Mar 1
9 citations
Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3
Anas Younes, Johannes Drach, Ruth L. Katz, David Jendiroba, M. H. Sabourian, Andreas H. Sarris, F. Swan, Debbie Hill, Fernando Cabanillas, Richard J. Ford, Michael And...> ;Annals of Oncology. 1994 Mar 1
40 citations
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood bcl-2 rearrangement
Patricia J. McLaughlin, Fredrick B. Hagemeister, F. Swan, Fernando Cabanillas, Jorge E. Romaguera, Maria A Rodriguez, M. S. Lee, Odeal Pate, Andreas H. Sarris, Anas Yo...> ;Annals of Oncology. 1994 Jan 1
21 citations
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy
Fredrick B. Hagemeister, Ronaldo V Purugganan, Lillian M. Fuller, Patricia J. McLaughlin, F. Swan, Jorge E. Romaguera, Maria A Rodriguez, Fernando Cabanillas> ;Seminars in Hematology. 1994 Jan 1
37 citations
Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.
Melerios A. Dimopoulos, Fernando Cabanillas, J. Jack Lee, F. Swan, Lillian M. Fuller, Pamela K. Allen, Fredrick B. Hagemeister> ;Journal of Clinical Oncology. 1993 Jun 1
45 citations
CHOP-Bleo plus interferon for stage IV low-grade lymphoma
P. McLaughlin, Fernando Cabanillas, Fredrick B. Hagemeister, F. Swan, J. E. Romaguera, S. Taylor, Maria A Rodriguez, W. S. Velasquez, John R. Redman, Jordan U. Gutterman> ;Annals of Oncology. 1993 Mar 1
85 citations
Original article: A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the ‘tumor score’
Juan Luis Polo Rodríguez, Fernando Cabanillas, Patricia J. McLaughlin, F. Swan, Maria A Rodriguez, Fredrick B. Hagemeister, Jorge E. Romaguera> ;Annals of Oncology. 1992 Nov 1
14 citations
NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Fredrick B. Hagemeister, Lillian M. Fuller, Patricia J. McLaughlin, Maria A Rodriguez, Jorge E. Romaguera, F. Swan, Fernando Cabanillas> ;Annals of Oncology. 1992 Sep 1
178 citations
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
John R. Redman, Fernando Cabanillas, W. S. Velasquez, Peter McLaughlin, Fredrick B. Hagemeister, F. Swan, Maria A Rodriguez, William Plunkett, Michael J. Keating> ;Journal of Clinical Oncology. 1992 May 1
24 citations
Therapy of relapsed or refractory low-grade follicular lymphomas: Factors associated with complete remission, survival and time to treatment failure
J. A. Spinolo, Fernando Cabanillas, Dennis O. Dixon, S. M. Khorana, P. McLaughlin, W. S. Velasquez, Fredrick B. Hagemeister, John R. Redman, F. Swan> ;Annals of Oncology. 1992 Mar 1
91 citations
Radiotherapy during pregnancy for clinical stages IA–IIA Hodgkin's disease
Shiao Y. Woo, Lillian M. Fuller, Jackson Cundiff, Melissa L. Bondy, Fredrick B. Hagemeister, Peter McLaughlin, W. S. Velasquez, F. Swan, M. Alma Rodriguez, Fernando Ca...> ;International Journal of Radiation Oncology, Biology, Physics. 1992 Jan 1
80 citations
Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma
Patrick Litam, F. Swan, Fernando Cabanillas, Susan L. Tucker, Peter McLaughlin, Fredrick B. Hagemeister, Maria A Rodriguez, W. S. Velasquez> ;Annals of Internal Medicine. 1991 May 15
Join now to see all

Hospital Affiliations

Mercy Regional Medical CenterDurango, Colorado
LeConte Medical CenterSevierville, Tennessee
Kona Community HospitalKealakekua, Hawaii
Charleston Area Medical CenterCharleston, West Virginia